WHO ICTRP trial
treatment strategy of primary esophageal small cell carcinoma: a multicenter…
ChiCTR2000040175 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2000040175 |
|---|---|
| Public title | treatment strategy of primary esophageal small cell carcinoma: a multicenter retrospective study |
| Scientific title | A multicenter retrospective study on the optimal treatment strategy for primary esophageal small cell carcinoma |
| Primary sponsor | Shandong Cancer Hospital and Institute |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | Retrospective study |
| Countries | China |
| Conditions | primary esophageal small cell carcinoma |
| Interventions | Group 1:radiotherapy and chemotherapy;Group 2:surgery and chemotherapy;conrtol group:chemotherapy |
| Registration date | Nov 24, 2020 |
| Target size | Group 1:50;Group 2:50;conrtol group:50 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: